Skip to content

Holly Health: Personalised, scalable health coaching intervention for patients living with hypertension, anxiety and/or depression

Holly Health: A feasibility randomised controlled trial of a personalised, scalable health coaching intervention for patients living with hypertension, anxiety and/or depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14391408
Enrollment
50
Registered
2023-12-06
Start date
2024-04-22
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition management for patients with hypertension and mild to moderate anxiety/depression Circulatory System

Interventions

Eligible primary care patients will be randomised to receive access to a digital health coaching service (Holly Health) as a self-management tool or to a waiting list control. Allocation to treatment

Sponsors

Holly Health
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female participants 2. 40-65 years old 3. Hypertension diagnosis 4. Mild to moderate symptoms of depression and/or anxiety 5. Fluent in English 6. Have a smartphone or tablet with internet access 7. Informed consent (written and witnessed)

Exclusion criteria

Exclusion criteria: 1. Having a current other major psychiatric disorder (e.g., major depression, major suicidality, substance dependence, psychosis) needing treatment in its own right 2. Having recently started psychotropic medication or increased the dose (i.e. within the previous 2 weeks) 3. Taking medication for weight loss 4. Visual impairments that cannot be corrected with contact lenses or glasses

Design outcomes

Primary

MeasureTime frame
Feasibility and acceptability of providing a digital health coach service to primary care patients living with hypertension and depression/anxiety by assessing recruitment, engagement, retention rates and qualitative feedback at 12 weeks and 6 months after initial signup.

Secondary

MeasureTime frame
1. Health behaviours measured using a bespoke questionnaire at baseline vs 8 weeks and 6 months post-signup 2. Personal wellbeing measured by ONS-4 at baseline vs 8 weeks and 6 months post-signup 3. Blood pressure readings at baseline vs 12 weeks and 6 months post-signup

Countries

England, United Kingdom

Contacts

Public ContactLiliana Chow
lily@hollyhealth.io+44 (0)7377699092

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026